This inventor holds 2 USPTO granted patents. Top assignee: University of Alberta. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Kimberley Zimmerman: Innovator in Hepatitis B Research
Introduction
Kimberley Zimmerman is a prominent inventor based in Edmonton, Canada. She has made significant contributions to the field of medical research, particularly in the area of hepatitis B virus (HBV) detection and treatment. With a focus on innovative solutions, her work has the potential to impact public health positively.
Latest Patents
Kimberley Zimmerman holds 2 patents related to hepatitis B virus-binding polypeptides. Her latest patents include non-naturally occurring polypeptides that specifically bind to HBV DNA. These inventions also encompass polynucleotides encoding the polypeptides. Furthermore, her patents provide methods for detecting HBV DNA, detecting a covalently closed circular DNA (cccDNA) form of HBV, and methods for treating HBV infection.
Career Highlights
Kimberley Zimmerman is affiliated with the University of Alberta, where she conducts her research and develops her innovative solutions. Her work is characterized by a commitment to advancing medical science and improving treatment options for hepatitis B.
Collaborations
Some of her notable coworkers include Michael A Joyce and Karl Fischer, who contribute to her research endeavors and collaborative projects.
Conclusion
Kimberley Zimmerman's contributions to hepatitis B research through her patents and work at the University of Alberta highlight her role as an influential inventor in the medical field. Her innovative approaches have the potential to enhance the detection and treatment of hepatitis B, ultimately benefiting public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile